Gepotidacin accepted for priority review by the US FDA for the oral treatment of uncomplicated uroge

Gepotidacin accepted for priority review by the US FDA for the oral treatment of uncomplicated urogenital gonorrhoea

Submission supported by positive phase III data in patients with uncomplicated urogenital gonorrhoea in EAGLE 1 trial

RSS Hunter • Aug 11, 2025